Skip to content

Clinical trials

Observational Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Observational Clear all

400 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20032
20043
20056
20065
20071
20089
20096
201012
201114
201210
201322
201421
201523
201615
201714
201821
201927
202016
202123
202227
202329
202432
202523
202630

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed153
Unknown status86
Recruiting75
Not yet recruiting28
Active, not recruiting19
Terminated16
Withdrawn13
Enrolling by invitation8
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris12
Hospices Civils de Lyon10
NYU Langone Health6
Northern Jiangsu People's Hospital6
Assiut University5
Beijing Friendship Hospital5
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5
Post Graduate Institute of Medical Education and Research, Chandigarh5
AbbVie4
Chinese University of Hong Kong4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis400
Liver Cirrhosis57
Carcinoma, Hepatocellular38
Hypertension, Portal35
Non-alcoholic Fatty Liver Disease31
Liver Diseases27
Fatty Liver22
Hepatitis C21
Hepatitis B16
Inflammation14

Trials

Showing 1 to 25 of 400. Each trial links to its page on Pharma Observatory.

300 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.